154 related articles for article (PubMed ID: 31359124)
1. Peritumoral ADC values in breast cancer: region of interest selection, associations with hyaluronan intensity, and prognostic significance.
Kettunen T; Okuma H; Auvinen P; Sudah M; Tiainen S; Sutela A; Masarwah A; Tammi M; Tammi R; Oikari S; Vanninen R
Eur Radiol; 2020 Jan; 30(1):38-46. PubMed ID: 31359124
[TBL] [Abstract][Full Text] [Related]
2. Peritumor to tumor apparent diffusion coefficient ratio is associated with biologically more aggressive breast cancer features and correlates with the prognostication tools.
Okuma H; Sudah M; Kettunen T; Niukkanen A; Sutela A; Masarwah A; Kosma VM; Auvinen P; Mannermaa A; Vanninen R
PLoS One; 2020; 15(6):e0235278. PubMed ID: 32584887
[TBL] [Abstract][Full Text] [Related]
3. Breast MRI for prediction of lymphovascular invasion in breast cancer patients with clinically negative axillary lymph nodes.
Igarashi T; Furube H; Ashida H; Ojiri H
Eur J Radiol; 2018 Oct; 107():111-118. PubMed ID: 30292254
[TBL] [Abstract][Full Text] [Related]
4. Apparent diffusion coefficient ratio between axillary lymph node with primary tumor to detect nodal metastasis in breast cancer patients.
Luo N; Su D; Jin G; Liu L; Zhu X; Xie D; Liu Y
J Magn Reson Imaging; 2013 Oct; 38(4):824-8. PubMed ID: 23440958
[TBL] [Abstract][Full Text] [Related]
5. The application of apparent diffusion coefficients derived from intratumoral and peritumoral zones for assessing pathologic prognostic factors in rectal cancer.
Yuan Y; Chen XL; Li ZL; Chen GW; Liu H; Liu YS; Pang MH; Liu SY; Pu H; Li H
Eur Radiol; 2022 Aug; 32(8):5106-5118. PubMed ID: 35320412
[TBL] [Abstract][Full Text] [Related]
6. Can whole-tumor apparent diffusion coefficient histogram analysis be helpful to evaluate breast phyllode tumor grades?
Guo Y; Tang WJ; Kong QC; Liang YY; Han XR; Zheng BJ; Sun L; Wei XH; Jin Z; Liu CL
Eur J Radiol; 2019 May; 114():25-31. PubMed ID: 31005172
[TBL] [Abstract][Full Text] [Related]
7. Assessment of axillary lymph nodes in patients with breast cancer with diffusion-weighted MR imaging in combination with routine and dynamic contrast MR imaging.
Razek AA; Lattif MA; Denewer A; Farouk O; Nada N
Breast Cancer; 2016 May; 23(3):525-32. PubMed ID: 25763535
[TBL] [Abstract][Full Text] [Related]
8. Predicting metastasis in clinically negative axillary lymph nodes with minimum apparent diffusion coefficient value in luminal A-like breast cancer.
Kato F; Kudo K; Yamashita H; Baba M; Shimizu A; Oyama-Manabe N; Kinoshita R; Li R; Shirato H
Breast Cancer; 2019 Sep; 26(5):628-636. PubMed ID: 30937834
[TBL] [Abstract][Full Text] [Related]
9. Role of diffusion-weighted MRI: predicting axillary lymph node metastases in breast cancer.
Chung J; Youk JH; Kim JA; Gweon HM; Kim EK; Ryu YH; Son EJ
Acta Radiol; 2014 Oct; 55(8):909-16. PubMed ID: 24234236
[TBL] [Abstract][Full Text] [Related]
10. Characterization of tumor and adjacent peritumoral stroma in patients with breast cancer using high-resolution diffusion-weighted imaging: Correlation with pathologic biomarkers.
Shin HJ; Park JY; Shin KC; Kim HH; Cha JH; Chae EY; Choi WJ
Eur J Radiol; 2016 May; 85(5):1004-11. PubMed ID: 27130063
[TBL] [Abstract][Full Text] [Related]
11. Magnetic resonance imaging features for predicting axillary lymph node metastasis in patients with breast cancer.
Zhao M; Wu Q; Guo L; Zhou L; Fu K
Eur J Radiol; 2020 Aug; 129():109093. PubMed ID: 32512504
[TBL] [Abstract][Full Text] [Related]
12. Early-stage invasive ductal carcinoma: Association of tumor apparent diffusion coefficient values with axillary lymph node metastasis.
Kim JY; Seo HB; Park S; Moon JI; Lee JW; Lee NK; Lee SW; Bae YT
Eur J Radiol; 2015 Nov; 84(11):2137-43. PubMed ID: 26318821
[TBL] [Abstract][Full Text] [Related]
13. Diagnostic performance of standard breast MRI compared to dedicated axillary MRI for assessment of node-negative and node-positive breast cancer.
Samiei S; Smidt ML; Vanwetswinkel S; Engelen SME; Schipper RJ; Lobbes MBI; van Nijnatten TJA
Eur Radiol; 2020 Aug; 30(8):4212-4222. PubMed ID: 32221685
[TBL] [Abstract][Full Text] [Related]
14. Dynamic contrast-enhanced and diffusion-weighted MRI of invasive breast cancer for the prediction of sentinel lymph node status.
Choi EJ; Youk JH; Choi H; Song JS
J Magn Reson Imaging; 2020 Feb; 51(2):615-626. PubMed ID: 31313393
[TBL] [Abstract][Full Text] [Related]
15. Diagnostic Performance of Fused Diffusion-Weighted Imaging Using T1-Weighted Imaging for Axillary Nodal Staging in Patients With Early Breast Cancer.
Kim SH; Shin HJ; Shin KC; Chae EY; Choi WJ; Cha JH; Kim HH
Clin Breast Cancer; 2017 Apr; 17(2):154-163. PubMed ID: 27843006
[TBL] [Abstract][Full Text] [Related]
16. Quantitative apparent diffusion coefficient measurement obtained by 3.0Tesla MRI as a potential noninvasive marker of tumor aggressiveness in breast cancer.
Durando M; Gennaro L; Cho GY; Giri DD; Gnanasigamani MM; Patil S; Sutton EJ; Deasy JO; Morris EA; Thakur SB
Eur J Radiol; 2016 Sep; 85(9):1651-8. PubMed ID: 27501902
[TBL] [Abstract][Full Text] [Related]
17. Diffusion-Weighted Magnetic Resonance Imaging of 103 Patients with Rectal Adenocarcinoma Identifies the Apparent Diffusion Coefficient as an Imaging Marker for Tumor Invasion and Regional Lymph Node Involvement.
Kargol J; Rudnicki W; Kenig J; Filipowska J; Kaznowska E; Kluz T; Guz W; Łuczyńska E
Med Sci Monit; 2021 Dec; 27():e934941. PubMed ID: 34871292
[TBL] [Abstract][Full Text] [Related]
18. Diffusion-Weighted Imaging in 3.0 Tesla Breast MRI: Diagnostic Performance and Tumor Characterization Using Small Subregions vs. Whole Tumor Regions of Interest.
Arponen O; Sudah M; Masarwah A; Taina M; Rautiainen S; Könönen M; Sironen R; Kosma VM; Sutela A; Hakumäki J; Vanninen R
PLoS One; 2015; 10(10):e0138702. PubMed ID: 26458106
[TBL] [Abstract][Full Text] [Related]
19. Diffusion weighted images of metastatic as compared with nonmetastatic axillary lymph nodes in patients with newly diagnosed breast cancer.
Yamaguchi K; Schacht D; Nakazono T; Irie H; Abe H
J Magn Reson Imaging; 2015 Sep; 42(3):771-8. PubMed ID: 25556886
[TBL] [Abstract][Full Text] [Related]
20. Does axillary lymph node size predict better metastatic involvement than apparent diffusion coefficient (ADC) value in women with newly diagnosed breast cancer?
Ramírez-Galván YA; Cardona-Huerta S; Elizondo-Riojas G; Álvarez-Villalobos NA; Campos-Coy MA; Ferrara-Chapa CM
Acta Radiol; 2020 Nov; 61(11):1494-1504. PubMed ID: 32064890
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
